292 related articles for article (PubMed ID: 33373644)
1. Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19.
Hamouche W; Bisserier M; Brojakowska A; Eskandari A; Fish K; Goukassian DA; Hadri L
J Mol Cell Cardiol; 2021 Apr; 153():72-85. PubMed ID: 33373644
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.
Tsatsakis A; Calina D; Falzone L; Petrakis D; Mitrut R; Siokas V; Pennisi M; Lanza G; Libra M; Doukas SG; Doukas PG; Kavali L; Bukhari A; Gadiparthi C; Vageli DP; Kofteridis DP; Spandidos DA; Paoliello MMB; Aschner M; Docea AO
Food Chem Toxicol; 2020 Dec; 146():111769. PubMed ID: 32979398
[TBL] [Abstract][Full Text] [Related]
3. First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
Jakob CEM; Borgmann S; Duygu F; Behrends U; Hower M; Merle U; Friedrichs A; Tometten L; Hanses F; Jung N; Rieg S; Wille K; Grüner B; Klinker H; Gersbacher-Runge N; Hellwig K; Eberwein L; Dolff S; Rauschning D; von Bergwelt-Baildon M; Lanznaster J; Strauß R; Trauth J; de With K; Ruethrich M; Lueck C; Nattermann J; Tscharntke L; Pilgram L; Fuhrmann S; Classen A; Stecher M; Schons M; Spinner C; Vehreschild JJ
Infection; 2021 Feb; 49(1):63-73. PubMed ID: 33001409
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis and management of myocardial injury in coronavirus disease 2019.
Wei ZY; Geng YJ; Huang J; Qian HY
Eur J Heart Fail; 2020 Nov; 22(11):1994-2006. PubMed ID: 32683753
[TBL] [Abstract][Full Text] [Related]
5. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and cardiovascular diseases.
Liu F; Liu F; Wang L
J Mol Cell Biol; 2021 Jul; 13(3):161-167. PubMed ID: 33226078
[TBL] [Abstract][Full Text] [Related]
7. An Insight Into Pathophysiology, Epidemiology, and Management of Cardiovascular Complications of SARS-CoV-2 Infection, Post-acute COVID Syndrome, and COVID Vaccine.
Davoudi F; Miyashita S; Yoo TK; Lee PT; Foster GP
Crit Pathw Cardiol; 2022 Sep; 21(3):123-129. PubMed ID: 35994720
[TBL] [Abstract][Full Text] [Related]
8. Impact of Cardiovascular Diseases on COVID-19: A Systematic Review.
Cao Q; Lei H; Yang M; Wei L; Dong Y; Xu J; Nasser M; Liu M; Zhu P; Xu L; Zhao M
Med Sci Monit; 2021 Apr; 27():e930032. PubMed ID: 33820904
[TBL] [Abstract][Full Text] [Related]
9. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.
Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P
Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC
JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and cardiovascular disease: manifestations, pathophysiology, vaccination, and long-term implication.
Abdel Moneim A; Radwan MA; Yousef AI
Curr Med Res Opin; 2022 Jul; 38(7):1071-1079. PubMed ID: 35575011
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment.
Luo J; Zhu X; Jian J; Chen X; Yin K
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):273-282. PubMed ID: 33428706
[TBL] [Abstract][Full Text] [Related]
13. An Overview on COVID-19 and its Effect on Cardiovascular Diseases.
Hamadi A; Mahzari A; Hakami A; Hindawi S; Dobie G; Sayyed MI; Hamdi F; Nahari M; Jackson DE
Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1949-1953. PubMed ID: 33371840
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 extrapulmonary illness - special gastrointestinal and hepatic considerations.
Perisetti A; Gajendran M; Mann R; Elhanafi S; Goyal H
Dis Mon; 2020 Sep; 66(9):101064. PubMed ID: 32807535
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and oncological disease.
Šálek T; Slopovský J; Pörsök Š; Pazderová N; Mináriková Z; Zomborská E; Špánik B
Klin Onkol; 2021; 34(3):211-219. PubMed ID: 34362259
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
Bajgain KT; Badal S; Bajgain BB; Santana MJ
Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease and COVID-19: Australian and New Zealand consensus statement.
Zaman S; MacIsaac AI; Jennings GL; Schlaich MP; Inglis SC; Arnold R; Kumar S; Thomas L; Wahi S; Lo S; Naismith C; Duffy SJ; Nicholls SJ; Newcomb A; Almeida AA; Wong S; Lund M; Chew DP; Kritharides L; Chow CK; Bhindi R
Med J Aust; 2020 Aug; 213(4):182-187. PubMed ID: 32734645
[TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
[TBL] [Abstract][Full Text] [Related]
19. The "Three Italy" of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia.
Prezioso C; Marcocci ME; Palamara AT; De Chiara G; Pietropaolo V
J Neurovirol; 2020 Jun; 26(3):311-323. PubMed ID: 32548750
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and the Heart.
Rojulpote C; Gonuguntla K; Patil S; Bhattaru A; Bravo PE
Colomb Med (Cali); 2020 Jun; 51(2):e4320. PubMed ID: 33012891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
